Roger M Castillo Ore
Overview
Explore the profile of Roger M Castillo Ore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castillo Ore R, Caceda R, Huaman A, Williams M, Hang J, Juarez D, et al.
PLoS One
. 2018 Jul;
13(7):e0200576.
PMID: 30024910
Group C orthobunyaviruses (GRCVs) are a complex of viruses in the genus Orthobunyavirus and are associated with human febrile disease in tropical and subtropical areas of South and Central America....
2.
Castillo Ore R, Forshey B, Huaman A, Villaran M, Long K, Kochel T, et al.
Vector Borne Zoonotic Dis
. 2012 May;
12(8):683-9.
PMID: 22616720
While human illness associated with hantavirus infection has been documented in many countries of South America, evidence for hantavirus transmission in Peru has been limited to the isolation of Rio...
3.
Maves R, Castillo Ore R, Porter K, Kochel T
Vaccine
. 2011 Feb;
29(15):2691-6.
PMID: 21303709
Psoralens are photoreactive compounds that cross-link pyrimidines after exposure to UVA radiation. In this experiment, we tested the protective efficacy of a psoralen-inactivated dengue vaccine candidate in non-human primates. Two...
4.
Maves R, Castillo Ore R, Porter K, Kochel T
Clin Vaccine Immunol
. 2009 Dec;
17(2):304-6.
PMID: 20007362
We evaluated a novel psoralen-inactivated dengue virus type 1 (DENV-1) vaccine candidate in Mus musculus mice. Mice received intradermal alum or 5 to 10 ng of psoralen-inactivated virus. Anti-DENV-1 neutralizing...